Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75742714 | 7574271 | 4 | F | 20100502 | 20160823 | 20100907 | 20160823 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-15271273 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 2.81000 | KG | 20160823 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75742714 | 7574271 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Transplacental | UNK | U | 21436 | TABLET | ||||||||
| 75742714 | 7574271 | 2 | SS | DIHYDROCODEINE | DIHYDROCODEINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75742714 | 7574271 | 3 | SS | LAMICTAL | LAMOTRIGINE | 1 | Transplacental | TABS | U | 0 | 400 | MG | BID | ||||||
| 75742714 | 7574271 | 4 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75742714 | 7574271 | 5 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75742714 | 7574271 | 6 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 75742714 | 7574271 | 7 | SS | NORETHISTERONE | NORETHINDRONE | 1 | Transplacental | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75742714 | 7574271 | 1 | Product used for unknown indication |
| 75742714 | 7574271 | 2 | Product used for unknown indication |
| 75742714 | 7574271 | 3 | Product used for unknown indication |
| 75742714 | 7574271 | 4 | Product used for unknown indication |
| 75742714 | 7574271 | 5 | Product used for unknown indication |
| 75742714 | 7574271 | 6 | Product used for unknown indication |
| 75742714 | 7574271 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75742714 | 7574271 | OT |
| 75742714 | 7574271 | CA |
| 75742714 | 7574271 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75742714 | 7574271 | Atrial septal defect | |
| 75742714 | 7574271 | Foetal exposure during pregnancy | |
| 75742714 | 7574271 | Premature baby | |
| 75742714 | 7574271 | Ventricular septal defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |